Report overview
Diabetes Testing Systems are the systems used at home or health care settings for monitoring the blood glucose levels in diabetic patients.?Testing blood glucose?level is the best way to understand diabetes and how different foods, medications, and other activities affect diabetes. Therefore, there is a need to keep a track of the blood glucose level in the body.
This report contains market size and forecasts of Diabetes Testing System in global, including the following market information:
Global Diabetes Testing System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetes Testing System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Diabetes Testing System companies in 2021 (%)
The global Diabetes Testing System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Self-Monitoring Diabetes Testing Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Testing System include Roche Holding AG, Abbott Laboratories, Sanofi S.A., ACON Laboratories, Nova Biomedical, Nipro Corporation, Braun Holding GmbH, DexCom and Medtronic Plc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Testing System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Testing System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetes Testing System Market Segment Percentages, by Type, 2021 (%)
Self-Monitoring Diabetes Testing Systems
Continuous Diabetes Testing Systems
Others
Global Diabetes Testing System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetes Testing System Market Segment Percentages, by Application, 2021 (%)
Home Care
Hospitals
Clinics
Others
Global Diabetes Testing System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetes Testing System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Testing System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetes Testing System revenues share in global market, 2021 (%)
Key companies Diabetes Testing System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Diabetes Testing System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Holding AG
Abbott Laboratories
Sanofi S.A.
ACON Laboratories
Nova Biomedical
Nipro Corporation
Braun Holding GmbH
DexCom
Medtronic Plc
ARKRAY
